Satyam Q3 net up 28.58% at Rs 433.63 crore (The Hindu Business Line 21th Jan 2008) IT major Satyam Computer Services Ltd on Monday posted an increase of 28.58 per cent in its net profit at Rs 433.63 crore for the third quarter ended December 31, 2007, against Rs 337.23 in the corresponding quarter of 2006.
Total income of the group rose 35.58 per cent at Rs 2266.05 crore for the quarter under review, compared to Rs 1671.29 crore in the same period last year, Satyam said in a filing to the Bombay Stock Exchange.
The standalone profit of the firm increased 28.45 per cent at Rs 441 crore for Q3 FY-08, against Rs 343.30 crore in the same quarter previous year.
Glenmark consolidated Q3 net soars 48% at Rs 280 crore (The Hindu Business Line 21th Jan 2008)Glenmark Pharmaceuticals Ltd on Monday reported a 48.17 per cent jump in consolidated profit for the quarter ended December 31, 2007 at Rs 280.02 crore compared to Rs 188.98 crore for the same period last year.
Consolidated revenue rose by 53.56 per cent to Rs 685.08 crore during the third quarter of this fiscal as against Rs 446.12 crore in the corresponding period of the previous year.
In a statement, the drug firm said estimated profit from generics business stood at Rs 89.28 crore and that of from specialty business was Rs 190.74 crore for the quarter.
ONGC Q3 net drops 6% to Rs 4,366cr (Business Standard 21th Jan 2008)Oil & Natural Gas Corporation (ONGC), the country's largest exploration and production company, today reported a 6.46% decline in net profit at Rs 4,366.54 crore for the quarter ended December 2007 when compared with Rs 4,668.31 crore in Q3FY07. More
Total income of the group rose 35.58 per cent at Rs 2266.05 crore for the quarter under review, compared to Rs 1671.29 crore in the same period last year, Satyam said in a filing to the Bombay Stock Exchange.
The standalone profit of the firm increased 28.45 per cent at Rs 441 crore for Q3 FY-08, against Rs 343.30 crore in the same quarter previous year.
Glenmark consolidated Q3 net soars 48% at Rs 280 crore (The Hindu Business Line 21th Jan 2008)Glenmark Pharmaceuticals Ltd on Monday reported a 48.17 per cent jump in consolidated profit for the quarter ended December 31, 2007 at Rs 280.02 crore compared to Rs 188.98 crore for the same period last year.
Consolidated revenue rose by 53.56 per cent to Rs 685.08 crore during the third quarter of this fiscal as against Rs 446.12 crore in the corresponding period of the previous year.
In a statement, the drug firm said estimated profit from generics business stood at Rs 89.28 crore and that of from specialty business was Rs 190.74 crore for the quarter.
ONGC Q3 net drops 6% to Rs 4,366cr (Business Standard 21th Jan 2008)Oil & Natural Gas Corporation (ONGC), the country's largest exploration and production company, today reported a 6.46% decline in net profit at Rs 4,366.54 crore for the quarter ended December 2007 when compared with Rs 4,668.31 crore in Q3FY07. More
Comments